Company intelligence / Profile preview

SkinCure Oncology

Burr Ridge, Illinois, United States

Ownership: Private
Employees: ~229
Development stage: Other

Overview

SkinCure Oncology has clinically deployed its Image-Guided SRT platform at over 410–500 dermatology practices in the US, with over 100,000 patients treated; its technology is shown as a leading non-surgical option for treating nonmelanoma skin cancers, with positive patient outcomes and broad physician adoption[1][2][3][4].

Therapeutic areas: Oncology
Modalities: DeviceRadiation therapy
Industry: Therapeutic Medical Devices

Partnerships

Partnerships with 410+ dermatology practices and Mohs surgeons (no evidence of major pharma/biotech partner)[2][3][4]

Beyond the preview

Go deeper on SkinCure Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SkinCure Oncology.

Explore the full profile